NCT02060188 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Nivolumab 3 mg/kg
- id
- FG000
- title
- Cohort 1: Nivolumab Monotherapy
- description
- Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg
- id
- FG001
- title
- Cohort 2: Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg
- description
- Nivolumab 3 mg/kg Q2W with Ipilimumab 1 mg/kg twice in six weeks Q6W
- id
- FG002
- title
- Cohort 3: Nivolumab 3 mg/kg Q2W with Ipilimumab 1 mg/kg Q6W
- description
- Nivolumab 3 mg/kg Q2W with Ipilimumab 1 mg/kg Q6W
- id
- FG003
- title
- MSS: Nivolumab 3 mg/kg Q2W with Ipilimumab 1 mg/kg Q6W
- description
- Nivolumab 1 mg/kg + Ipilimumab 3 mg/kg
- id
- FG004
- title
- Non-MSI-H: Nivolumab 1 mg/kg + Ipilimumab 3 mg/kg
- description
- Nivolumab 1 mg/kg + Ipilimumab 1 mg/kg
- id
- FG005
- title
- Non-MSI-H: Nivolumab 1 mg/kg + Ipilimumab 1 mg/kg
- description
- Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg + Cobimetinib 60 mg
- id
- FG006
- title
- Cohort 4: Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg + Cobimetinib 60 mg
- description
- Nivolumab 240 mg + BMS-986016 80 mg
- id
- FG007
- title
- Cohort 5: Nivolumab 240 mg + BMS-986016 80 mg
- description
- Nivolumab FD + Daratumumab 16 mg/kg
- id
- FG008
- title
- Cohort 6: Nivolumab FD + Daratumumab 16 mg/kg
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 36
- group Id
- FG001
- num Subjects
- 42
- group Id
- FG002
- num Subjects
- 8
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 23
- group Id
- FG007
- num Subjects
- 20
- group Id
- FG008
- num Subjects
- 43
- type
- Disease Progression
- reasons
- group Id
- FG000
- num Subjects
- 10
- group Id
- FG001
- num Subjects
- 18
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 4
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 2
- group Id
- FG007
- num Subjects
- 5
- group Id
- FG008
- num Subjects
- 0
- type
- Study Drug Toxicity
- reasons
- group Id
- FG000
- num Subjects
- 2
- group Id
- FG001
- num Subjects
- 5
- group Id
- FG002
- num Subjects
- 6
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 4
- group Id
- FG008
- num Subjects
- 1
- type
- Adverse event unrelated to study drug
- reasons
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 7
- group Id
- FG002
- num Subjects
- 4
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 1
- group Id
- FG008
- num Subjects
- 0
- type
- Participant request to discontinue study treatment
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- group Id
- FG008
- num Subjects
- 0
- type
- Participant withdrew consent
- reasons
- group Id
- FG000
- num Subjects
- 13
- group Id
- FG001
- num Subjects
- 38
- group Id
- FG002
- num Subjects
- 19
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 10
- group Id
- FG008
- num Subjects
- 0
- type
- Maximum clinical benefit
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 7
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 9
- group Id
- FG008
- num Subjects
- 0
- type
- Other reason
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 1
- group Id
- FG008
- num Subjects
- 0
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- group Id
- FG008
- num Subjects
- 0
- type
- Administrative reasons by sponsor
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- group Id
- FG008
- num Subjects
- 0
- type
- Lost to Follow-up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 74
- group Id
- FG001
- num Subjects
- 119
- group Id
- FG002
- num Subjects
- 45
- group Id
- FG003
- num Subjects
- 10
- group Id
- FG004
- num Subjects
- 10
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 30
- group Id
- FG007
- num Subjects
- 50
- group Id
- FG008
- num Subjects
- 44
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- group Id
- FG008
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 74
- group Id
- FG001
- num Subjects
- 119
- group Id
- FG002
- num Subjects
- 45
- group Id
- FG003
- num Subjects
- 10
- group Id
- FG004
- num Subjects
- 10
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 30
- group Id
- FG007
- num Subjects
- 50
- group Id
- FG008
- num Subjects
- 44
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Nivolumab 3 mg/kg
- id
- FG000
- title
- Cohort 1: Nivolumab Monotherapy
- description
- Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg
- id
- FG001
- title
- Cohort 2: Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg
- description
- Nivolumab 3 mg/kg Q2W with Ipilimumab 1 mg/kg twice in six weeks Q6W
- id
- FG002
- title
- Cohort 3: Nivolumab 3 mg/kg Q2W with Ipilimumab 1 mg/kg Q6W
- description
- Nivolumab 3 mg/kg Q2W with Ipilimumab 1 mg/kg Q6W
- id
- FG003
- title
- MSS: Nivolumab 3 mg/kg Q2W with Ipilimumab 1 mg/kg Q6W
- description
- Nivolumab 1 mg/kg + Ipilimumab 3 mg/kg
- id
- FG004
- title
- Non-MSI-H: Nivolumab 1 mg/kg + Ipilimumab 3 mg/kg
- description
- Nivolumab 1 mg/kg + Ipilimumab 1 mg/kg
- id
- FG005
- title
- Non-MSI-H: Nivolumab 1 mg/kg + Ipilimumab 1 mg/kg
- description
- Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg + Cobimetinib 60 mg
- id
- FG006
- title
- Cohort 4: Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg + Cobimetinib 60 mg
- description
- Nivolumab 240 mg + BMS-986016 80 mg
- id
- FG007
- title
- Cohort 5: Nivolumab 240 mg + BMS-986016 80 mg
- description
- Nivolumab FD + Daratumumab 16 mg/kg
- id
- FG008
- title
- Cohort 6: Nivolumab FD + Daratumumab 16 mg/kg
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 36
- group Id
- FG001
- num Subjects
- 42
- group Id
- FG002
- num Subjects
- 8
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 23
- group Id
- FG007
- num Subjects
- 20
- group Id
- FG008
- num Subjects
- 43
- type
- Disease Progression
- reasons
- group Id
- FG000
- num Subjects
- 10
- group Id
- FG001
- num Subjects
- 18
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 4
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 2
- group Id
- FG007
- num Subjects
- 5
- group Id
- FG008
- num Subjects
- 0
- type
- Study Drug Toxicity
- reasons
- group Id
- FG000
- num Subjects
- 2
- group Id
- FG001
- num Subjects
- 5
- group Id
- FG002
- num Subjects
- 6
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 4
- group Id
- FG008
- num Subjects
- 1
- type
- Adverse event unrelated to study drug
- reasons
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 7
- group Id
- FG002
- num Subjects
- 4
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 1
- group Id
- FG008
- num Subjects
- 0
- type
- Participant request to discontinue study treatment
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- group Id
- FG008
- num Subjects
- 0
- type
- Participant withdrew consent
- reasons
- group Id
- FG000
- num Subjects
- 13
- group Id
- FG001
- num Subjects
- 38
- group Id
- FG002
- num Subjects
- 19
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 10
- group Id
- FG008
- num Subjects
- 0
- type
- Maximum clinical benefit
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 7
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 9
- group Id
- FG008
- num Subjects
- 0
- type
- Other reason
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 1
- group Id
- FG008
- num Subjects
- 0
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- group Id
- FG008
- num Subjects
- 0
- type
- Administrative reasons by sponsor
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- group Id
- FG008
- num Subjects
- 0
- type
- Lost to Follow-up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 74
- group Id
- FG001
- num Subjects
- 119
- group Id
- FG002
- num Subjects
- 45
- group Id
- FG003
- num Subjects
- 10
- group Id
- FG004
- num Subjects
- 10
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 30
- group Id
- FG007
- num Subjects
- 50
- group Id
- FG008
- num Subjects
- 44
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- group Id
- FG008
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 74
- group Id
- FG001
- num Subjects
- 119
- group Id
- FG002
- num Subjects
- 45
- group Id
- FG003
- num Subjects
- 10
- group Id
- FG004
- num Subjects
- 10
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 30
- group Id
- FG007
- num Subjects
- 50
- group Id
- FG008
- num Subjects
- 44
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle